Frontiers in Immunology (May 2017)

The Transcription Factor ZNF683/HOBIT Regulates Human NK-Cell Development

  • Mirte Post,
  • Angelica Cuapio,
  • Markus Osl,
  • Dorit Lehmann,
  • Ulrike Resch,
  • David M. Davies,
  • Martin Bilban,
  • Bernhard Schlechta,
  • Wolfgang Eppel,
  • Amit Nathwani,
  • Dagmar Stoiber,
  • Dagmar Stoiber,
  • Jan Spanholtz,
  • Emilio Casanova,
  • Emilio Casanova,
  • Erhard Hofer

DOI
https://doi.org/10.3389/fimmu.2017.00535
Journal volume & issue
Vol. 8

Abstract

Read online

We identified ZNF683/HOBIT as the most highly upregulated transcription factor gene during ex vivo differentiation of human CD34+ cord blood progenitor cells to CD56+ natural killer (NK) cells. ZNF683/HOBIT mRNA was preferentially expressed in NK cells compared to other human peripheral blood lymphocytes and monocytes. During ex vivo differentiation, ZNF683/HOBIT mRNA started to increase shortly after addition of IL-15 and further accumulated in parallel to the generation of CD56+ NK cells. shRNA-mediated knockdown of ZNF683/HOBIT resulted in a substantial reduction of CD56−CD14− NK-cell progenitors and the following generation of CD56+ NK cells was largely abrogated. The few CD56+ NK cells, which escaped the developmental inhibition in the ZNF683/HOBIT knockdown cultures, displayed normal levels of NKG2A and KIR receptors. Functional analyses of these cells showed no differences in degranulation capacity from control cultures. However, the proportion of IFN-γ-producing cells appeared to be increased upon ZNF683/HOBIT knockdown. These results indicate a key role of ZNF683/HOBIT for the differentiation of the human NK-cell lineage and further suggest a potential negative control on IFN-γ production in more mature human NK cells.

Keywords